Relative Bioavailability Study of HU6

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This is a 2-part study. Part 1 will assess the relative bioavailability of the new 450 mg tablet test formulation compared to the 150 mg capsule reference formulation (3 x 150 mg). Part 1 dosing will be conducted in the fasted state. Part 2 will assess the effect of food (and fat content) on the pharmacokinetics of the 450 mg tablet test formulation.
Epistemonikos ID: 161750ef2cdd1ab0597358cccc27c359d82fa362
First added on: Apr 17, 2025